TUSTIN, CA, December 09, 2012 (Press-News.org) V2 Cigs has been in the business of offering quality e-cigarette products for years now. It has been the trusted brand of most Americans, and has been voted as America's Number 1 Electronic Cigarette by Alexa.com. Being one of the best e cigarette brands in the market, V2 Cigs has an average of one million site visitors every month. So to give back to its millions of customers and supporters, V2 Cigs has partnered with EcigaretteReviewed.com to offer huge discounts on all of the brand's products in time for Christmas.
V2 Cigs has already dropped its prices for the coming season, but V2 Cigs Holiday Coupon Code will help customers get the most out of their V2 Shopping Carts this Christmas. This Holiday offering will offer customers up to 15% off on some of the best e-cigarette products in the market, and 10% off on all other already-discounted items. This offers customers double discounts the ultimate e-cigarette experience this Christmas.
V2 Cigs also designed a starter kit exclusively for the Holidays. The V2 Holiday Starter Kit will provide customers all the essentials so they can switch from conventional cigarettes to e-cigarettes with ease. The Holiday Starter Pack has also been marked down for this season, from $74.95 to just $49.95. It will be a great Christmas gift option this Christmas.
The V2 Holiday Starter Kit will include:
- 1 V2 Standard White Automatic Battery
- 1 V2 Standard White Manual Battery
- 5 V2 Flavor Cartridges
- 1 V2 Soft Case
- 1 Wall Adapter
- 1 Smart Charger
- 1 V2 Manual
V2 Cigs Holiday Coupon Code
To get the best deals on their e-cigarette purchases this season, customers must key in the following exclusive coupon codes upon checking out:
- ECR15KITS to save 15% on all V2 Cigs Starter Kits
- ECR10ALL to save 10% on all items in the store, including already-discounted products
Get more information on how to use the V2 Cigs promo codes.
EcigaretteReviewed.com is the first and only e-cigarette review site in the world which allows users to rank their favorite products on the site. Since 2010, the website has been educating the public on the benefits of electronic cigarettes, while encouraging them to make the switch to e-cigarettes from conventional cigarettes. The website gives users the power to rate their favorite e-cigarette products and rank them accordingly on a Top 10 chart. This allows new users to read honest user reviews and to identify the best rated e-cigarettes on the market that could help them choose the brand that best suits their needs.
Website: http://ecigarettereviewed.com
V2 Cigs Offers Holiday Discount Coupons On All E-Cigarette Products
V2 Cigs and EcigeretteReviewed.com announce V2 Cigs Holiday Coupon Code. This allows customers to shop at 15% discount on Starter Kits and 10% off on all already-discounted E Cigarettes products.
2012-12-09
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Online Bingo at Its Best, Thanks to Bingo Reviewer!
2012-12-09
There's quite a mishmash of bingo sites, different offers, warnings about some venues, good and bad player reviews, forum posts, bonuses and other features that new players should take into consideration before they can feel confident they've made the right choice of the online bingo room where they'll deposit their money and play.
In such a jungle where experience is an essential tool, there's a ray of light that delivers hope for those who are not willing to experiment and risk their money on just any bingo site; and the ray comes in shape of online bingo resource ...
Film Vet Ashaine Briscoe Enters the Spotlight with Quirky, Heartfelt New Shorts
2012-12-09
Filmmaker Ashaine Briscoe has just made her debut as a screenwriter, director, and producer--but to call her a novice would be an incredible oversight. In reality, Briscoe has been working in film for years, developing an almost preternaturally accomplished and diverse resume that includes credits as a Production Assistant, an Art Director, and more. She has worked on TV commercials and music videos, and her keen eye and visual flair have landed her design spots in leading glamour magazines. Now, however, it is Briscoe's time to shine, and to unleash the full extent of ...
Investigational agent targets gene signaling pathways to improve response for patients with CLL
2012-12-08
(ATLANTA, December 8, 2012) –The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic lymphocytic leukemia (CLL), according to studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH).
CLL is a blood cancer that causes abnormal white blood cells called lymphocytes to accumulate in the blood, bone marrow, and in the lymph nodes or other organs, causing these organs to enlarge. Approximately 15,000 ...
Researchers develop novel 3-D culture system for inflammatory breast cancer
2012-12-08
SAN ANTONIO, TX (December 8, 2012)—Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment. Researchers at Fox Chase Cancer Center have developed a novel, 3D culture system that mimics the environment surrounding these cancer cells. This model could be used to test new anticancer drugs capable of inhibiting the spread of IBC tumors.
"The tumor ...
Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
2012-12-08
(ATLANTA, December 8, 2012) – Research identifying genetic factors that affect survival of patients with blood cancers and evaluating the effectiveness of modified treatment strategies to improve outcomes while reducing toxicity will be presented today at the 54th Annual Meeting of the American Society of Hematology (ASH).
While the cancer research community has seen many significant therapeutic advances over the last decade, only recently have investigators identified how patients' individual genetic makeup influences their short- and long-term response to therapy, demonstrating ...
Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2012-12-08
COLUMBUS, Ohio – Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.
The agent, ibrutinib (PCI-32765), is the first drug designed to target Bruton's tyrosine kinase (BTK), a protein essential for CLL-cell survival and proliferation. CLL is the most common form of leukemia, with about 15,000 new cases annually in the U.S. About 4,400 Americans die of the disease each year.
Study co-leader Dr. ...
137 new species described by California Academy of Sciences in 2012
2012-12-08
SAN FRANCISCO (December 6, 2012) — In 2012, researchers at the California Academy of Sciences added 137 new relatives to our family tree, enriching our understanding of the complex web of life on Earth and strengthening our ability to make informed conservation decisions. The new species include 83 arthropods, 41 fishes, seven plants, four sea slugs, one reptile, and one amphibian. Specimens ranged from Eviota goby fishes housed in museum collections for more than 30 years (reported in the October 12 issue of Zootaxa), to Trogloraptor cave spiders collected just two years ...
Mayo Clinic IDs genes that predict whether trastuzumab will work for breast cancer patients
2012-12-08
SAN ANTONIO, Texas -- Adding the drug trastuzumab to chemotherapy prevents cancer recurrence and improves survival in a large number of women with early stage HER2-positive breast cancer. But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment. This situation may soon change, according to a Mayo Clinic study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium.
VIDEO ALERT: Video of Dr. Perez is available on the Mayo Clinic News Network.
A team ...
New small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer
2012-12-08
SAN ANTONIO, TX (December 7, 2012)—Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor.
Mesupron® is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a recent phase II clinical study suggest that the drug could be a safe and first-line treatment that extends progression-free survival for metastatic ...
Green scientists propose safety testing system for development of new chemicals
2012-12-08
PITTSBURGH—A group of scientists from North America and Europe, including Carnegie Mellon University's Terry Collins, has developed a five-tiered testing system that manufacturers can use to ensure that the chemicals and consumer products they produce are free of harmful endocrine disrupting chemicals like BPA or DDT. Their study, "Designing Endocrine Disruption Out of the Next Generation of Chemicals," will be published in the January 2013 issue of the Royal Society of Chemistry journal Green Chemistry, and is currently available online.
Endocrine disrupting chemicals, ...
LAST 30 PRESS RELEASES:
Keeping pediatrics afloat in a sea of funding cuts
Giant resistivity reduction in thin film a key step towards next-gen electronics for AI
First pregnancy with AI-guided sperm recovery method developed at Columbia
Global study reveals how bacteria shape the health of lakes and reservoirs
Biochar reimagined: Scientists unlock record-breaking strength in wood-derived carbon
Synthesis of seven quebracho indole alkaloids using "antenna ligands" in 7-10 steps, including three first-ever asymmetric syntheses
BioOne and Max Planck Society sign 3-year agreement to include subscribe to open pilot
How the arts and science can jointly protect nature
Student's unexpected rise as a researcher leads to critical new insights into HPV
Ominous false alarm in the kidney
MSK Research Highlights, October 31, 2025
Lisbon to host world’s largest conference on ecosystem restoration in 2027, led by researcher from the Faculty of Sciences, University of Lisbon
Electrocatalysis with dual functionality – an overview
Scripps Research awarded $6.9 million by NIH to crack the code of lasting HIV vaccine protection
New post-hoc analysis shows patients whose clinicians had access to GeneSight results for depression treatment are more likely to feel better sooner
First transplant in pigs of modified porcine kidneys with human renal organoids
Reinforcement learning and blockchain: new strategies to secure the Internet of Medical Things
Autograph: A higher-accuracy and faster framework for compute-intensive programs
Expansion microscopy helps chart the planktonic universe
Small bat hunts like lions – only better
As Medicaid work requirements loom, U-M study finds links between coverage, better health and higher employment
Manifestations of structural racism and inequities in cardiovascular health across US neighborhoods
Prescribing trends of glucagon-like peptide 1 receptor agonists for type 2 diabetes or obesity
Continuous glucose monitoring frequency and glycemic control in people with type 2 diabetes
Bimodal tactile tomography with bayesian sequential palpation for intracavitary microstructure profiling and segmentation
IEEE study reviews novel photonics breakthroughs of 2024
New method for intentional control of bionic prostheses
Obesity treatment risks becoming a ‘two-tier system’, researchers warn
Researchers discuss gaps, obstacles and solutions for contraception
Disrupted connectivity of the brainstem ascending reticular activating system nuclei-left parahippocampal gyrus could reveal mechanisms of delirium following basal ganglia intracerebral hemorrhage
[Press-News.org] V2 Cigs Offers Holiday Discount Coupons On All E-Cigarette ProductsV2 Cigs and EcigeretteReviewed.com announce V2 Cigs Holiday Coupon Code. This allows customers to shop at 15% discount on Starter Kits and 10% off on all already-discounted E Cigarettes products.